InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Finished Goods (2023 - 2025)

InflaRx's (IFRX) quarterly Finished Goods came in at $60874.5 in Q2 2025, up 21.41% year-over-year from $50138.8 in Q2 2024, and up 0.6% quarter-over-quarter from $60511.4 in Q4 2024.

Analysis

InflaRx (IFRX) Finished Goods (2023 - 2025) Analysis & Trends

InflaRx has disclosed Finished Goods across 3 years of filings, most recently posting $60874.5 for Q2 2025.

  • In Q2 2025, Finished Goods rose 21.41% year-over-year to $60874.5; the TTM figure through Jun 2025 stood at $60874.5 (up 21.41% YoY), while the FY2024 annual figure was $60511.4, down 82.96% from the prior year.
  • Finished Goods came in at $60874.5 for Q2 2025 at InflaRx, up from $60511.4 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $355153.8 in Q4 2023 to a low of $50138.8 in Q2 2024.
  • Average Finished Goods over 3 years is $131669.6, with a median of $60692.9 recorded in 2024.
  • Year-over-year, Finished Goods plunged 82.96% in 2024 and climbed 21.41% in 2025.
  • Over 3 years, Finished Goods stood at $355153.8 in 2023, then sank by 82.96% to $60511.4 in 2024, then rose by 0.6% to $60874.5 in 2025.
  • Per Business Quant data, the three most recent Finished Goods figures were $60874.5 in Q2 2025, $60511.4 in Q4 2024, and $50138.8 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 60,874.53
Dec 31, 2024 60,511.35
Jun 30, 2024 50,138.81
Dec 31, 2023 355,153.78